TARDBP and neurodegenerative disease: The dysregulation of TDP-43 is hence associated with a variety of human diseases, especially neurodegenerative diseases, e.g., frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), brain ischemia, aging, and Alzheimer’s disease [11,12,13].